BASF optimizes global sterols production infrastructure

An FDA approved claim states that 1.3 grams of plant sterols per day may reduce the risk of heart disease. Image: © iStockPhoto
An FDA approved claim states that 1.3 grams of plant sterols per day may reduce the risk of heart disease. Image: © iStockPhoto
BASF is increasing its sterol extraction capacity at its site in Boussens, France, and closing its sterols production site in Pasadena, Texas as the company optimizes its global sterol production infrastructure.

The Pasadena plant, which manufactures wood and vegetable sterols, will close by the end of 2015, said the company, with 37 positions affected by the closure. The site is remotely located from the key raw material sources, and does not allow BASF to remain competitive in the marketplace, added the company.

The company considers sterols to be an important product range in its human nutrition portfolio, and will continue to manufacture the ingredients without interruption at other sites in Europe and the United States.

Sterols are typically used in dietary supplements and as functional ingredients in food products to reduce cholesterol. Numerous clinical trials in controlled settings have reported that daily consumption of 1.5 to 3 grams of phyto-sterols/-stanols from foods can reduce total cholesterol levels by eight to 17%, representing a significant reduction in the risk of cardiovascular disease.

The US FDA approved health claim states​ that 1.3 grams of plant sterols per day as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. (For plant stanols, the daily dose increases to 3.4 grams)

Related news

Show more

Related products

show more

Support a new era of active lifestyle consumers

Support a new era of active lifestyle consumers

Content provided by Lonza | 05-Nov-2024 | Product Brochure

Mobility is taking center stage for a new generation of consumers who understand that mobility and joint health are inextricably linked to long-term quality...

BB536 for optimal Gut health and beyond

BB536 for optimal Gut health and beyond

Content provided by Morinaga Milk Industry Co., Ltd. | 03-Oct-2024 | White Paper

Among the various probiotics strains available, Bifidobacterium longum BB536 stands out due to its well-documented safety, efficacy, and regulatory approvals....

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Embrace Active Aging and ENJOY life!

Embrace Active Aging and ENJOY life!

Content provided by IFF | 05-Sep-2024 | Product Brochure

Live life to the fullest, regardless of age. Our science-backed formulas, packed with clinically studied probiotics and botanicals, empower you to age...

Related suppliers

Follow us

Products

View more

Webinars